# Cognitive Neurology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Emile Griffith (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX005-SYN
- Date: 2026-05-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Celeste Fairbanks-Ochieng, MD
- Calendar frame: modern shifted

- To: Rafael Haddad-Lindgren, MD, Cognitive Neurology
- Urgency: Routine; at the memory clinic two weeks from now, on the same day as his two-week primary care visit, with brain MRI that morning

## Referral question

About a year of memory loss and confusion in a retired professional boxer of 67 with a long career, a severe assault with a head injury thirteen years ago, and chronic PTSD; MoCA 22. Please stage the impairment, weigh traumatic brain injury and traumatic encephalopathy syndrome against Alzheimer's disease, vascular disease and the effects of PTSD and depression, and advise on further testing, treatment and safety. **S**

## Questions for the consultant

1. What is the stage of his impairment, and what pattern does it show?
2. How likely are traumatic brain injury and traumatic encephalopathy syndrome as the cause, compared with Alzheimer's disease or vascular disease, and how much might PTSD, depression and sleep be adding?
3. Which further tests do you advise: neuropsychological testing, Alzheimer's disease biomarkers, or others?
4. Is any medicine for cognition indicated, and is sertraline a reasonable choice for his PTSD from a cognitive point of view?
5. What do you advise for safety when he travels, for falls, and for support for his care partner?

## Pertinent history

Retired world champion boxer: 112 professional bouts over nineteen years, ending at 39. Thirteen years ago he was beaten by a group of men, one with a baseball bat, and spent several months in hospital, much of it in intensive care; short-term memory problems have been noticed since, worse over the past year: repeated stories and questions, losing the thread of conversations, mixing up days, two missed appointments, and once getting lost changing trains on a familiar route. Independent in personal care; reminders for appointments and help with bills (Functional Activities Questionnaire 6). MoCA 22 with losses in delayed recall (helped by cues), trail, cube, clock and letter fluency. Chronic PTSD diagnosed today: lifelong nightmares and distress about a title fight decades ago after which his opponent died, and about the assault; PC-PTSD-5 4, PCL-5 41; PHQ-9 9 with item 9 scored 0; safety assessment done with no ideation, intent or plan, and no firearms at home. Started today on sertraline 25 mg each morning, with cognitive processing therapy to begin; no other medicines and no sleep aids. Blood count, metabolic panel (sodium 140 mmol/L, creatinine 1.0 mg/dL), B12 418 pg/mL and TSH 2.1 normal. STOP-Bang 2. Timed Up and Go 13 seconds with one fall on ice last winter; physical therapy ordered. No tobacco; AUDIT-C 2. He does not drive. His care partner comes to visits. **S**

- Emile Alphonse Griffith was born on February 3, 1938, in St. Thomas, U.S. Virgin Islands, one of eight children. **D**
- He moved to New York City as a young man and turned professional in 1958. **D**
- He boxed professionally for nineteen years, from 1958 to 1977, in 112 bouts (a record of 85 wins, 24 losses and 2 draws), won five world titles at welterweight and middleweight, was the first boxer from the U.S. Virgin Islands to become a world champion, and retired at 39, after losing his last three fights; he entered the International Boxing Hall of Fame in 1990. **D**
- On March 24, 1962, at Madison Square Garden, he regained the welterweight title by stopping Benny Paret in the twelfth round; Paret never regained consciousness, had emergency brain surgery, and died ten days later. Sports Illustrated reported in 2005 that an anti-gay slur Paret directed at him at the weigh-in may have fueled him. **D**
- The fight's outcome stayed with him for decades. His biographer said he saw visions of Paret at night and in a mirror and refused to box again for months; Griffith said he was "never the same fighter after that"; and in a documentary released in 2005 he told Paret's son, "Sometimes I still have nightmares." **D**
- The project roster describes post-traumatic stress disorder from the ring death. No source read records that diagnosis; the documented nightmares, visions and lasting distress are consistent with it only as a retrospective interpretation. **R**
- Over the years he described himself at various times as straight, gay and bisexual; in a 2005 interview with Sports Illustrated he said, "I don't know what I am." His biographer said he lived openly, going to gay bars, but did not say so publicly until after the 2005 documentary about him. **D**
- In 1992 he was attacked and badly beaten by a group of men, one with a baseball bat, after leaving a gay bar in midtown Manhattan near Times Square; he spent several months in hospital, much of it in intensive care. The motive was never established. **D**
- A 2005 review of the documentary reported that he had had short-term memory problems since the 1992 attack. **D**
- After boxing he trained other boxers, including world champions, and worked as a corrections officer and a bartender. **D**

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: White blood cells: 6.1 10*3/uL; Hemoglobin: 14.2 g/dL; Platelets: 228 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 1 mg/dL; eGFR (CKD-EPI 2021): 82 mL/min/1.73 m²; Glucose: 94 mg/dL; Calcium: 9.4 mg/dL; Vitamin B12: 418 pg/mL; TSH: 2.1 mIU/L; MoCA: 22; PHQ-9: 9; PC-PTSD-5: 4; PCL-5: 41. All results are synthetic.

BP 134/80 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 74 kg; BMI 25.6 kg/m². All vital signs are synthetic.

## Current medications

- Sertraline 25 mg oral tablet, one tablet each morning **S**

## Plan so far

- Cognitive work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression and PTSD screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a medicine review for anticholinergic and sedating drugs, a sleep apnea screen, hearing and vision checks, and brain MRI. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
- PTSD treatment by shared decision: cognitive processing therapy with the clinic psychologist, weekly for about twelve sessions, adapted for memory problems; and sertraline 25 mg each morning, raised to 50 mg after four to six weeks if tolerated, with sodium checked two weeks after starting and after the increase; benzodiazepines avoided. Guideline: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023) **S**
- Collaborative safety plan with warning signs, coping steps, people to call, the clinic number and the 988 Suicide & Crisis Lifeline; medicines kept by his care partner; PHQ-9 item 9 and safety reviewed at every visit. Guideline: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Falls: STEADI assessment, physical therapy for balance and strength with a home program, and a home safety check. Guideline: CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026); STEADI (Stopping Elderly Accidents, Deaths and Injuries): Clinical Resources (2024) **S**
- Measurement-based care: PCL-5 and PHQ-9 at each chronic-care visit during treatment; MoCA yearly or sooner with change; medicine review every visit. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
- Advance care planning while he can take part fully: a health care agent, his values and goals of care, at the annual wellness visit. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
